AYTU — Aytu Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $19.98m
- $10.71m
- $57.57m
Annual cashflow statement for Aytu Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -110 | -17.1 | -15.8 | -13.6 | -14.3 |
| Depreciation | |||||
| Non-Cash Items | 82 | 8.91 | 10.8 | 12 | 7.77 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.9 | -5.8 | -4.66 | -5.73 | 5.83 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -28.8 | -5.13 | -1.39 | -1.94 | 3.28 |
| Capital Expenditures | — | — | — | -3.23 | -0.029 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.25 | -0.117 | -0.329 | 0.668 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.25 | -0.117 | -0.329 | -2.56 | -0.029 |
| Financing Cash Flow Items | -4.94 | -4.36 | -2.84 | -6.07 | -3.05 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.53 | 8.87 | -1.26 | 15.4 | -7.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -30.5 | 3.63 | -2.98 | 10.9 | -4.64 |